• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型三唑衍生物的设计、合成及作为 Aurora-A 激酶抑制剂的生化评价。

Design, Synthesis, and Biochemical Evaluation of New Triazole Derivatives as Aurora-A Kinase Inhibitors.

机构信息

College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.

出版信息

Molecules. 2021 Sep 18;26(18):5678. doi: 10.3390/molecules26185678.

DOI:10.3390/molecules26185678
PMID:34577149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8469531/
Abstract

Aurora-A kinase, a key mitosis regulator, is expressed in a cell cycle-dependent manner and has an essential role in maintaining chromosomal stability and the normal progression of the cell through mitosis. Aurora-A kinase is overexpressed in many malignant solid tumors, such as breast, ovarian, colon, and pancreatic cancers. Thus, inhibiting Aurora-A kinase activity is a promising approach for cancer treatment. Here, new triazole derivatives were designed as bioisosteric analogues of the known inhibitor JNJ-7706621. The new compounds showed interesting inhibitory activity against Aurora-A kinase, as attested by ICs in the low to submicromolar range.

摘要

极光激酶 A 是一种关键的有丝分裂调节因子,其表达具有细胞周期依赖性,在维持染色体稳定性和细胞有丝分裂的正常进程中起着重要作用。极光激酶 A 在许多恶性实体瘤中过度表达,如乳腺癌、卵巢癌、结肠癌和胰腺癌。因此,抑制极光激酶 A 的活性是癌症治疗的一种有前途的方法。在这里,新的三唑衍生物被设计为已知抑制剂 JNJ-7706621 的生物等排体类似物。新化合物对极光激酶 A 表现出有趣的抑制活性,其 IC 在低至亚微摩尔范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/c415df232357/molecules-26-05678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/701304f45d7a/molecules-26-05678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/0705e6ca5e6f/molecules-26-05678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/c415df232357/molecules-26-05678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/701304f45d7a/molecules-26-05678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/0705e6ca5e6f/molecules-26-05678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342c/8469531/c415df232357/molecules-26-05678-g003.jpg

相似文献

1
Design, Synthesis, and Biochemical Evaluation of New Triazole Derivatives as Aurora-A Kinase Inhibitors.新型三唑衍生物的设计、合成及作为 Aurora-A 激酶抑制剂的生化评价。
Molecules. 2021 Sep 18;26(18):5678. doi: 10.3390/molecules26185678.
2
Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors.通过点击化学方法发现1,2,3-三唑基水杨酰胺作为有效的极光激酶抑制剂。
Bioorg Med Chem. 2014 Sep 1;22(17):4855-66. doi: 10.1016/j.bmc.2014.06.047. Epub 2014 Jun 30.
3
Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.基于结构的药物设计:作为选择性 Aurora A 激酶抑制剂的喹唑啉-4-胺衍生物的合成与生物评价。
Eur J Med Chem. 2018 Sep 5;157:1361-1375. doi: 10.1016/j.ejmech.2018.08.053. Epub 2018 Aug 23.
4
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
5
Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA).基于结构的新型 Aurora-A 激酶抑制剂的发现和生物活性评价作为抗癌剂通过基于对接的比较分子间接触分析 (dbCICA)。
Molecules. 2020 Dec 18;25(24):6003. doi: 10.3390/molecules25246003.
6
Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.设计、合成及生物评价 N-三取代嘧啶衍生物作为新型 Aurora A 激酶抑制剂。
Eur J Med Chem. 2014 May 6;78:65-71. doi: 10.1016/j.ejmech.2014.03.027. Epub 2014 Mar 12.
7
Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties.辅酶 A 类似物作为 Aurora 激酶 A 抑制剂的设计与合成:焦磷酸和泛肽部分的作用研究。
Bioorg Med Chem. 2020 Nov 15;28(22):115740. doi: 10.1016/j.bmc.2020.115740. Epub 2020 Sep 5.
8
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.设计和合成靶向 Aurora 激酶后口袋的 BPR1K653 衍生物,以实现选择性同工酶抑制。
Eur J Med Chem. 2018 May 10;151:533-545. doi: 10.1016/j.ejmech.2018.03.064. Epub 2018 Apr 3.
9
Optimization and biological evaluation of nicotinamide derivatives as Aurora kinase inhibitors.烟酰胺衍生物作为 Aurora 激酶抑制剂的优化及生物学评价。
Bioorg Med Chem. 2019 Sep 1;27(17):3825-3835. doi: 10.1016/j.bmc.2019.07.016. Epub 2019 Jul 11.
10
Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors.2-氨基苯并噻唑衍生物作为极光激酶B抑制剂的优化及生物学评价
Bioorg Med Chem. 2017 Jul 15;25(14):3614-3622. doi: 10.1016/j.bmc.2017.04.004. Epub 2017 Apr 6.

引用本文的文献

1
Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation.新型双苯并咪唑-三唑杂化物:抗癌研究、计算机模拟方法及作用机制研究
Future Med Chem. 2025 Jan;17(1):93-107. doi: 10.1080/17568919.2024.2437980. Epub 2024 Dec 13.

本文引用的文献

1
Genome instability in multiple myeloma.多发性骨髓瘤中的基因组不稳定性。
Leukemia. 2020 Nov;34(11):2887-2897. doi: 10.1038/s41375-020-0921-y. Epub 2020 Jul 10.
2
The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.双细胞周期激酶抑制剂JNJ-7706621可逆转活化B细胞样弥漫性大B细胞淋巴瘤细胞系对CD37靶向放射免疫疗法的耐药性。
Front Oncol. 2019 Nov 29;9:1301. doi: 10.3389/fonc.2019.01301. eCollection 2019.
3
The functional diversity of Aurora kinases: a comprehensive review.
极光激酶的功能多样性:全面综述
Cell Div. 2018 Sep 19;13:7. doi: 10.1186/s13008-018-0040-6. eCollection 2018.
4
Aurora-A Kinase as a Promising Therapeutic Target in Cancer.极光激酶A作为一种有前景的癌症治疗靶点
Front Oncol. 2016 Jan 6;5:295. doi: 10.3389/fonc.2015.00295. eCollection 2015.
5
Aurora Kinase Inhibitors: Current Status and Outlook.极光激酶抑制剂:现状与展望
Front Oncol. 2015 Dec 21;5:278. doi: 10.3389/fonc.2015.00278. eCollection 2015.
6
Small-molecule library screening by docking with PyRx.使用PyRx进行对接的小分子文库筛选。
Methods Mol Biol. 2015;1263:243-50. doi: 10.1007/978-1-4939-2269-7_19.
7
Quantification of protein kinase enzymatic activity in unfractionated cell lysates using CSox-based sensors.使用基于CSox的传感器对未分级细胞裂解物中的蛋白激酶酶活性进行定量分析。
Curr Protoc Chem Biol. 2014 Sep 9;6(3):135-156. doi: 10.1002/9780470559277.ch140106.
8
An unusual conformational similarity of two peptide folds featuring sulfonamide and carboxamide on the backbone.两个具有磺酰胺和羧酰胺骨架的肽折叠的不寻常构象相似性。
Chem Commun (Camb). 2012 Oct 9;48(78):9747-9. doi: 10.1039/c2cc34533a.
9
Aurora-A kinase inhibitor scaffolds and binding modes.极光激酶抑制剂骨架和结合模式。
Drug Discov Today. 2011 Mar;16(5-6):260-9. doi: 10.1016/j.drudis.2010.12.003. Epub 2010 Dec 13.
10
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.AutoDock4 和 AutoDockTools4:具有选择性受体柔性的自动化对接。
J Comput Chem. 2009 Dec;30(16):2785-91. doi: 10.1002/jcc.21256.